Dwight H Egan

“Thank you, everyone, for joining us today and for your continued support of co-diagnostics. This past quarter marked another important step in our transition from platform development toward commercialization.”

“Thank you, everyone, for joining us today and for your continued support of co-diagnostics. This continues to be an active and important period for our business as we execute on the opportunities ahead and remain focused on positioning the company for its next phase of growth.”

“Thank you, everyone, for joining us today and for your continued support of Codiagnostics. This continues to be one of the most active and strategically important periods in our company's history. as we execute on the significant opportunity ahead of us and continue to implement our multi-pronged growth strategy.”

“Thank you, everyone, for joining us today and for your continued support of Co-Diagnostics. As we head into the final stretch of the year, it is shaping up to be one of the most active and important times for our business.”

“The second quarter of this year continued to bring steady advancements of our Co-DX PCR point-of-care platform, and thanks to the diligent efforts of our team working towards our goal to bring the instrument to market.”